R. Waugh, J. Morrow, L. Roberts, and R. Murphy, Identification and Relative Quantitation of F2-Isoprostane Regioisomers Formed in vivo in the Rat, Free Radical Biology and Medicine, vol.23, issue.6, pp.943-54, 1997.
DOI : 10.1016/S0891-5849(97)00133-0

J. Cracowski, T. Durand, and G. Bessard, Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications, Trends in Pharmacological Sciences, vol.23, issue.8, pp.360-366, 2002.
DOI : 10.1016/S0165-6147(02)02053-9

M. Reilly, N. Delanty, and L. Roy, Increased formation of the isoprostanes IPF 2a -I and 8- epi-prostaglandin F 2a in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans 8-epi PGF 2a generation during coronary reperfusion Vascular biology of the isoprostanes, Circulation Circulation J Vasc Res, vol.9695386, issue.11, pp.3314-33202492, 1997.

S. Marlière, J. Cracowski, and T. Durand, -isoprostanes possess no vasomotor effects in the rat thoracic aorta, the human internal mammary artery and the human saphenous vein, British Journal of Pharmacology, vol.53, issue.5, pp.1276-1280, 2002.
DOI : 10.1038/sj.bjp.0704558

L. Iuliano, D. Pratico, and C. Greco, Angioplasty increases coronary sinus F 2 -isoprostane formation: evidence for in vivo oxidative stress during PTCA Transcardiac 8-iso-prostaglandin F 2a generation from acute myocardial infarction heart: insight into abrupt reperfusion and oxidant stress, J Am Coll Cardiol Prostaglandins Leukot Essent Fatty Acids, vol.3764, issue.13, pp.76-80161, 2001.

J. Cracowski, S. Marliere, and G. Bessard, Vasomotor effects and pathophysiologic relevance of F2-isoprostane formation in vascular diseases, Journal of the American College of Cardiology, vol.39, issue.3, p.554, 2002.
DOI : 10.1016/S0735-1097(01)01751-X

H. Miyawaki, Y. Wang, and M. Ashraf, Oxidant stress with hydrogen peroxide attenuates calcium paradox injury: role of protein kinase C and ATP-sensitive potassium channel, Cardiovascular Research, vol.37, issue.3
DOI : 10.1016/S0008-6363(97)00249-6

A. Sharma and M. Singh, Protein kinase C activation and cardioprotective effect of preconditioning with oxidative stress in isolated rat heart, Molecular and Cellular Biochemistry, vol.219, issue.1/2, pp.1-6, 2001.
DOI : 10.1023/A:1011038531656

G. Lebuffe, P. Schumacker, and Z. Shao, Reactive Oxygen and Nitrogen Species Trigger Early Preconditioning: Relationship to the Mitochondrial KATP Channel, Am J Physiol Heart Circ Physiol, vol.26, p.26, 2002.

J. Starkopf, T. Andreasen, E. Bugge, and Y. K. , Lipid peroxidation, arachidonic acid and products of the lipoxygenase pathway in ischaemic preconditioning of rat heart, Cardiovascular Research, vol.37, issue.1, pp.66-75, 1998.
DOI : 10.1016/S0008-6363(97)00240-X

T. Durand, J. Cracowski, A. Guy, and J. Rossi, Syntheses and preliminary pharmacological evaluation of the two epimers of the 5-F2t-isoprostane, Bioorganic & Medicinal Chemistry Letters, vol.11, issue.18, pp.2495-2503, 2001.
DOI : 10.1016/S0960-894X(01)00473-5

F. Cipollone, G. Ciabattoni, and P. Patrignani, Oxidant Stress and Aspirin-Insensitive Thromboxane Biosynthesis in Severe Unstable Angina, Circulation, vol.102, issue.9, pp.1007-1020, 2000.
DOI : 10.1161/01.CIR.102.9.1007

A. Tsuchida, Y. Liu, G. Liu, M. Cohen, and J. Downey, alpha 1-adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C, Circulation Research, vol.75, issue.3, pp.576-85, 1994.
DOI : 10.1161/01.RES.75.3.576

D. Hearse and S. Fj, Catecholamines and preconditioning: studies of contraction and function in isolated rat hearts, Am J Physiol, vol.277, issue.1 2, pp.136-179, 1999.

Y. Liu, A. Tsuchida, M. Cohen, and J. Downey, Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts, Journal of Molecular and Cellular Cardiology, vol.27, issue.3, pp.883-92, 1995.
DOI : 10.1016/0022-2828(95)90038-1

B. Kromer and J. Tippins, Coronary artery constriction by the isoprostane 8-epi prostaglandin F2??, British Journal of Pharmacology, vol.298, issue.Suppl., pp.1276-1280, 1996.
DOI : 10.1111/j.1476-5381.1996.tb16033.x

J. Möbert, B. Becker, S. Zahler, and E. Gerlach, Hemodynamic Effects of Isoprostanes (8-Iso-Prostaglandin F2?? and E2) in Isolated Guinea Pig Hearts, Journal of Cardiovascular Pharmacology, vol.29, issue.6, pp.789-794, 1997.
DOI : 10.1097/00005344-199706000-00012

J. Cracowski, F. Stanke-labesque, and P. Devillier, Human internal mammary artery contraction by isoprostaglandin F2?? type-III (8-iso-prostaglandin F2??), European Journal of Pharmacology, vol.397, issue.1, pp.161-168, 2000.
DOI : 10.1016/S0014-2999(00)00217-X

B. Kromer and J. Tippins, in the hypoxic rat heart, British Journal of Pharmacology, vol.317, issue.5, pp.1171-1175, 1999.
DOI : 10.1038/sj.bjp.0702433

S. Wilson, P. Best, and L. Lerman, Enhanced coronary vasoconstriction to oxidative stress product, 8-epi-prostaglandinF2??, in experimental hypercholesterolemia, Cardiovascular Research, vol.44, issue.3, pp.601-608, 1999.
DOI : 10.1016/S0008-6363(99)00225-4